The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Maxwell, James
    Cfo born in December 1984
    Individual (17 offsprings)
    Officer
    2024-02-15 ~ now
    OF - director → CIF 0
  • 2
    Silver, Gabrielle Alison
    Ceo born in September 1973
    Individual (16 offsprings)
    Officer
    2024-02-15 ~ now
    OF - director → CIF 0
  • 3
    LIBRETTO BIDCO LIMITED - 2021-10-29
    Suite A, Greenway House, Larkwood Way, Tytherington Business Park, Macclesfield, United Kingdom
    Corporate (3 parents, 5 offsprings)
    Profit/Loss (Company account)
    -21,539,692 GBP2022-10-01 ~ 2023-09-30
    Person with significant control
    2021-07-13 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 6
  • 1
    Bennett, Stephen William
    Born in January 1948
    Individual (3 offsprings)
    Officer
    2012-05-21 ~ 2021-07-13
    OF - director → CIF 0
  • 2
    Smith, Graeme David
    Pharmaceutical Consulting born in February 1964
    Individual
    Officer
    2012-05-21 ~ 2022-09-01
    OF - director → CIF 0
    Mr Graeme David Smith
    Born in February 1964
    Individual
    Person with significant control
    2016-04-06 ~ 2021-07-13
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
  • 3
    Gordon, James Douglas Strachan
    Solicitor born in July 1961
    Individual (66 offsprings)
    Officer
    2012-01-19 ~ 2012-05-21
    OF - director → CIF 0
  • 4
    Chaffer, Daniel
    Director born in August 1977
    Individual (6 offsprings)
    Officer
    2021-07-13 ~ 2023-07-14
    OF - director → CIF 0
  • 5
    Stanton, Matthew James
    Pharmaceutical Consulting born in August 1967
    Individual (4 offsprings)
    Officer
    2012-05-21 ~ 2019-11-07
    OF - director → CIF 0
    Mr Matthew James Stanton
    Born in August 1967
    Individual (4 offsprings)
    Person with significant control
    2016-04-06 ~ 2019-11-07
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 6
    Medley, Andrew John
    Director born in December 1967
    Individual (4 offsprings)
    Officer
    2021-07-13 ~ 2024-04-19
    OF - director → CIF 0
parent relation
Company in focus

AZIMUTH PHARMA LIMITED

Previous name
AZIMUTH MEDICAL LIMITED - 2012-01-23
Standard Industrial Classification
70100 - Activities Of Head Offices
Brief company account
Average Number of Employees
02022-10-01 ~ 2023-09-30
02021-10-01 ~ 2022-09-30
Fixed Assets - Investments
526,636 GBP2023-09-30
526,637 GBP2022-09-30
Fixed Assets
526,636 GBP2023-09-30
526,637 GBP2022-09-30
Cash at bank and in hand
94 GBP2022-09-30
Current Assets
94 GBP2022-09-30
Creditors
Current, Amounts falling due within one year
-70,469 GBP2023-09-30
-70,564 GBP2022-09-30
Net Current Assets/Liabilities
-70,469 GBP2023-09-30
-70,470 GBP2022-09-30
Total Assets Less Current Liabilities
456,167 GBP2023-09-30
456,167 GBP2022-09-30
Net Assets/Liabilities
456,167 GBP2023-09-30
456,167 GBP2022-09-30
Equity
Called up share capital
5 GBP2023-09-30
5 GBP2022-09-30
5 GBP2021-10-01
Capital redemption reserve
5 GBP2023-09-30
5 GBP2022-09-30
5 GBP2021-10-01
Retained earnings (accumulated losses)
456,157 GBP2023-09-30
456,157 GBP2022-09-30
456,157 GBP2021-10-01
Equity
456,167 GBP2023-09-30
456,167 GBP2022-09-30
456,167 GBP2021-10-01
Amounts owed to group undertakings
Current
70,469 GBP2023-09-30
70,564 GBP2022-09-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
525 shares2023-09-30
525 shares2022-09-30
Par Value of Share
Class 1 ordinary share
0.012022-10-01 ~ 2023-09-30
Related profiles found in government register
  • AZIMUTH PHARMA LIMITED
    Info
    AZIMUTH MEDICAL LIMITED - 2012-01-23
    Registered number 07916512
    Suite A, Greenway House Larkwood Way, Tytherington Business Park, Macclesfield SK10 2XR
    Private Limited Company incorporated on 2012-01-19 (13 years 4 months). The company status is Active.
    The last date of confirmation statement was made at 2025-01-23
    CIF 0
  • AZIMUTH PHARMA LIMITED
    S
    Registered number 07916512
    Ropewalks, Newton Street, Macclesfield, England, SK11 6QJ
    Limited Company in Registrat Of Companies - England & Wales, England
    CIF 1
  • AZIMUTH PHARMA LIMITED
    S
    Registered number 07916512
    Suite A, Greenway House, Larkwood Way, Tytherington Business Park, Macclesfield, United Kingdom, SK10 2XR
    Limited Company in Registrat Of Companies - England & Wales, England
    CIF 2
child relation
Offspring entities and appointments
Active 2
  • 1
    Suite A, Greenway House Larkwood Way, Tytherington Business Park, Macclesfield, England
    Corporate (3 parents, 1 offspring)
    Equity (Company account)
    5,547,775 GBP2023-09-30
    Person with significant control
    2016-04-06 ~ now
    CIF 2 - Ownership of shares – 75% or more → OE
    CIF 2 - Ownership of voting rights - 75% or more → OE
    CIF 2 - Right to appoint or remove directors → OE
  • 2
    Ropewalks, Newton St, Macclesfield, United Kingdom
    Dissolved corporate (2 parents)
    Equity (Company account)
    1 GBP2022-09-30
    Person with significant control
    2016-04-06 ~ dissolved
    CIF 1 - Ownership of shares – 75% or more → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE
    CIF 1 - Right to appoint or remove directors → OE

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.